| 000 | 01597 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250517082439.0 | ||
| 264 | 0 | _c20161213 | |
| 008 | 201612s 0 0 eng d | ||
| 022 | _a1879-2472 | ||
| 024 | 7 |
_a10.1016/j.thromres.2016.01.012 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSchellings, M W M | |
| 245 | 0 | 0 |
_aDetermination of dabigatran and rivaroxaban by ultra-performance liquid chromatography-tandem mass spectrometry and coagulation assays after major orthopaedic surgery. _h[electronic resource] |
| 260 |
_bThrombosis research _cMar 2016 |
||
| 300 |
_a128-34 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAnticoagulants _xblood |
| 650 | 0 | 4 |
_aBlood Coagulation _xdrug effects |
| 650 | 0 | 4 |
_aChromatography, High Pressure Liquid _xmethods |
| 650 | 0 | 4 |
_aDabigatran _xblood |
| 650 | 0 | 4 |
_aDrug Monitoring _xmethods |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOrthopedic Procedures _xadverse effects |
| 650 | 0 | 4 |
_aRivaroxaban _xblood |
| 650 | 0 | 4 |
_aTandem Mass Spectrometry _xmethods |
| 650 | 0 | 4 |
_aVenous Thromboembolism _xetiology |
| 700 | 1 | _aBoonen, K | |
| 700 | 1 | _aSchmitz, E M H | |
| 700 | 1 | _aJonkers, F | |
| 700 | 1 | _avan den Heuvel, D J | |
| 700 | 1 | _aBesselaar, A | |
| 700 | 1 | _aHendriks, J G E | |
| 700 | 1 | _avan de Kerkhof, D | |
| 773 | 0 |
_tThrombosis research _gvol. 139 _gp. 128-34 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.thromres.2016.01.012 _zAvailable from publisher's website |
| 999 |
_c25770828 _d25770828 |
||